-
公开(公告)号:US20050233417A1
公开(公告)日:2005-10-20
申请号:US10495235
申请日:2002-11-12
申请人: David Cooper , Ann Procter , John Gregory , David Millar , Mark Lewis , Angeles Ulied
发明人: David Cooper , Ann Procter , John Gregory , David Millar , Mark Lewis , Angeles Ulied
IPC分类号: G01N33/53 , A61K48/00 , A61P19/00 , A61P43/00 , C07K14/61 , C07K16/26 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12P21/00 , C12Q1/68 , C07H21/04
CPC分类号: C07K14/61 , C12Q1/6883 , C12Q2600/156
摘要: The present invention relates to naturally-occurring growth hormone mutations; to a method for detecting them and their use in screening patients for growth hormone irregularities or for producing variant proteins suitable for treating such irregularities. In one aspect there is disclosed variants of GH1, selected from the group consisting of: (a) (i) +480 C→T; (ii) +446 C→T; (iii) +1491 C→G; (iv) −60 G→A; (v) −40 to −39 GG→CT; (vi) −360 A→G; and (vii) +748 A→G (where figures relate to GH1 nucleotide position number, counting from TSS); (b) a sequence substantially homologous to or that hybridises to sequence (a) under stringent conditions; (c) a sequence substantially homologous to or that hybridises to the sequences (a) or (b) but for degeneracy of the genetic code; and (d) an oligonucleotide specific for any of the sequences (a), (b) or (c) above.
摘要翻译: 本发明涉及天然存在的生长激素突变; 检测它们的方法及其在筛选患者生长激素不规则或用于产生适于治疗这种不规则的变体蛋白质的用途。 一方面,公开了GH1的变体,其选自:(a)(i)+480C-> T; (ii)+446 C-> T; (iii)+1491 C-> G; (iv)-60 G-> A; (v)-40至-39 GG-> CT; (vi)-360 A-> G; 和(vii)+748 A-> G(其中数字涉及GH1核苷酸位置号,从TSS计数); (b)在严格条件下与序列(a)基本同源或杂交的序列; (c)与序列(a)或(b)基本上同源或杂交的序列,但是遗传密码的简并性; 和(d)对上述(a),(b)或(c)中任一项的特异性寡核苷酸。
-
公开(公告)号:US20060166209A1
公开(公告)日:2006-07-27
申请号:US10535005
申请日:2003-11-04
申请人: David Cooper , Ann Procter , John Gregory , David Millar , Mark Lewis , Angeles Ulied
发明人: David Cooper , Ann Procter , John Gregory , David Millar , Mark Lewis , Angeles Ulied
IPC分类号: C12Q1/68
CPC分类号: C07K16/40 , A61K38/00 , C07K14/61 , C12Q1/37 , C12Q2600/156 , G01N33/6803
摘要: The present invention relates to a naturally-occurring growth hormone mutation; to a method for detecting it and its use in screening patients for growth hormone dysfunction or for producing variant proteins suitable for treating such irregularities.
摘要翻译: 本发明涉及天然存在的生长激素突变; 检测它的方法及其在筛选患者生长激素功能障碍或用于产生适于治疗这种不规则的变体蛋白质中的用途。
-